We explore the potential of miRNA as a cancer biomarker and its potential for future tumour diagnostics in oncology.
Follow the movement of money in the pharma industry over the last week - stay on the pulse of the latest mergers and collaborations
Blockchains promise solutions to the growing complexity of global supply chains and the need to adhere to new regulations for transparency.
Macrocyclic drugs offer a bridge between traditional small molecules and biologic drugs. We explore current work on them.
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settings
